High rate of complete remisions (CR) with concomitant chemoradiotherapy (QRT) in esophageal cancer (EC).: Preliminary results in a phase II trial.

被引:0
|
作者
Balmana, J
Brunet, J
Balart, J
Rodriguez, MR
Montesinos, J
Rius, X
Gallen, M
Arcusa, A
Pardo, B
Marcuello, E
López, JJL
机构
[1] Hosp St Pau, Med Oncol Serv, Barcelona, Spain
[2] Hosp St Pau, Serv Radioterapia, Barcelona, Spain
[3] Hosp St Pau, Serv Cirugia, Barcelona, Spain
[4] Hosp Del Mar, Serv Oncol, Barcelona, Spain
[5] Gen Hosp, Terrassa, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S75 / S75
页数:1
相关论文
共 50 条
  • [21] Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: Results of a phase II trial
    Keresztes, RS
    Port, JL
    Pasmantier, MW
    Korst, RJ
    Altorki, NK
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (05): : 1603 - 1608
  • [22] Doxil and gemcitabine combination therapy for recurrent ovarian cancer: Results of a phase II trial.
    Holloway, RW
    Finkler, NJ
    Nye, LP
    Bigsby, GE
    Ortiz, BH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 471S - 471S
  • [23] Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial
    Liang, Jun
    E, Mingyan
    Wu, Gang
    Zhao, Lujun
    Li, Xia
    Xiu, Xia
    Li, Ning
    Chen, Bo
    Hui, Zhouguang
    Lv, Jima
    Fang, Hui
    Tang, Yu
    Bi, Nan
    Wang, Wenqing
    Zhai, Yirui
    Li, Tao
    Chen, Dongfu
    Zou, Shuangmei
    Lu, Ning
    Perez-Rodriguez, Rolando
    Zheng, Junqi
    Wang, Luhua
    ONCOTARGETS AND THERAPY, 2013, 6 : 1589 - 1596
  • [24] Nimotuzumab combined with radiotherapy on esophageal cancer: Preliminary study of a phase II clinical trial
    Liang, Jun
    Wang, Luhua
    Mingyan, E.
    Gang, Wu
    Zhao, Lujun
    Li, Xia
    Xiu, Xia
    Li, Ning
    Chen, Bo
    Hui, Zhouguang
    Lv, Jima
    Fang, Hui
    Tang, Yu
    Bi, Nan
    Wang, Wenqing
    Zhai, Yirui
    Li, Tao
    Chen, Dongfu
    Zou, Shuangmei
    Lu, Ning
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Ultra-hypofractionated SABR in High risk prostate cancer: preliminary results of a phase II trial
    Montero, A.
    Rossi, K.
    Hernando, O.
    Lopez, M.
    Valero, J.
    Canadillas, C.
    Chen-Zhao, X.
    Ciervide, R.
    Garcia-Aranda, M.
    Alvarez, B.
    Prado, A.
    Alonso, R.
    Sanchez, E.
    Izquierdo, M.
    Fernandez-Leton, P.
    Rubio, C.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1194 - S1195
  • [26] NEOADJUVANT ELECTROCHEMOTHERAPY IN SQUAMOUS VULVAR CANCER: PRELIMINARY RESULTS OF A PHASE II TRIAL
    Borghese, G.
    Della Gatta, A. N.
    Ferioli, M.
    Procaccini, M.
    Dondi, G.
    Livi, A.
    Tesei, M.
    Corti, B.
    Galuppi, A.
    Morganti, A. G.
    Perrone, A. M.
    De Iaco, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 583 - 583
  • [27] Stereotactic radiotherapy for prostate cancer: preliminary results of a phase II prospective trial
    Nguyen, V. P.
    Alzin, H.
    Celine, L.
    Harzee, L.
    Joseph, S.
    Untereiner, M.
    Frederick, B.
    Biver, S.
    Bodgal, Z.
    Philippi, S.
    Nickers, P.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S58 - S59
  • [28] NEOADJUVANT ELECTROCHEMOTHERAPY IN SQUAMOUS VULVAR CANCER: PRELIMINARY RESULTS OF A PHASE II TRIAL
    Borghese, G.
    Della Gatta, A. N.
    Ferioli, M.
    Procaccini, M.
    Dondi, G.
    Livi, A.
    Tesei, M.
    Corti, B.
    Galuppi, A.
    Morganti, A. G.
    Perrone, A. M.
    De Iaco, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1881 - 1881
  • [29] Preliminary results of the Prostacox phase II trial in hormonal refractory prostate cancer
    Albouy, Baptiste
    Tourani, Jean-Marc
    Allain, Patrick
    Rolland, Frederic
    Staerman, Frederic
    Eschwege, Pascal
    Pfister, Christian
    BJU INTERNATIONAL, 2007, 100 (04) : 770 - 774
  • [30] Radiosensitization of locally advanced breast cancer with herceptin - initial toxicity results of a phase II trial.
    Sartor, CI
    Graham, M
    Carey, L
    Dees, C
    Ollila, D
    Sherron, R
    Halle, J
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S181 - S181